NCT05465278View on ClinicalTrials.gov

Alirocumab and Plaque Burden In Familial Hypercholesterolaemia

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Familial Hypercholesterolemia
Interventions
DRUG

Alirocumab

18 months treatment with alirocumab

Trial Locations (1)

28010

Fundacion Hipercolesterolemia Familiar, Madrid

All Listed Sponsors
lead

Fundación Hipercolesterolemia Familiar

OTHER

NCT05465278 - Alirocumab and Plaque Burden In Familial Hypercholesterolaemia | Biotech Hunter | Biotech Hunter